AXDX
Price:
$1.73
Market Cap:
$40.97M
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk....[Read more]
Industry
Medical - Devices
IPO Date
1994-04-07
Stock Exchange
NASDAQ
Ticker
AXDX
According to Accelerate Diagnostics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.28. This represents a change of -124.59% compared to the average of 5.20 of the last 4 quarters.
The mean historical PE Ratio of Accelerate Diagnostics, Inc. over the last ten years is -11.62. The current -1.28 PE Ratio has changed 1.00% with respect to the historical average. Over the past ten years (40 quarters), AXDX's PE Ratio was at its highest in in the September 2023 quarter at 22.80. The PE Ratio was at its lowest in in the March 2015 quarter at -28.23.
Average
-11.62
Median
-9.01
Minimum
-27.06
Maximum
-0.79
Discovering the peaks and valleys of Accelerate Diagnostics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.00%
Maximum Annual PE Ratio = -0.79
Minimum Annual Increase = -77.49%
Minimum Annual PE Ratio = -27.06
Year | PE Ratio | Change |
---|---|---|
2023 | -0.79 | -14.97% |
2022 | -0.93 | -77.49% |
2021 | -4.15 | -23.61% |
2020 | -5.43 | -50.32% |
2019 | -10.93 | 54.00% |
2018 | -7.10 | -68.51% |
2017 | -22.53 | 40.55% |
2016 | -16.03 | -24.58% |
2015 | -21.25 | -21.47% |
2014 | -27.06 | -9.84% |
The current PE Ratio of Accelerate Diagnostics, Inc. (AXDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.96
5-year avg
-4.45
10-year avg
-11.62
Accelerate Diagnostics, Inc.’s PE Ratio is greater than CVRx, Inc. (-3.35), greater than NeuroPace, Inc. (-6.95), greater than Anika Therapeutics, Inc. (-4.91), greater than AxoGen, Inc. (-34.41), greater than Artivion, Inc. (-125.20), greater than Sight Sciences, Inc. (-6.06), greater than Orthofix Medical Inc. (-5.12), less than Avanos Medical, Inc. (141.40), less than CONMED Corporation (23.18), greater than OrthoPediatrics Corp. (-28.25), greater than Surmodics, Inc. (-393.30), less than Integer Holdings Corporation (41.14), less than ProSomnus, Inc. Common Stock (-0.59), greater than LivaNova PLC (-154.03), less than Electromed, Inc. (28.81), greater than Pulmonx Corporation (-4.92), less than IRadimed Corporation (30.49),
Company | PE Ratio | Market cap |
---|---|---|
-3.35 | $183.44M | |
-6.95 | $210.22M | |
-4.91 | $363.41M | |
-34.41 | $570.66M | |
-125.20 | $1.05B | |
-6.06 | $319.45M | |
-5.12 | $619.96M | |
141.40 | $1.09B | |
23.18 | $2.29B | |
-28.25 | $742.41M | |
-393.30 | $553.99M | |
41.14 | $4.33B | |
-0.59 | $8.18M | |
-154.03 | $2.56B | |
28.81 | $149.02M | |
-4.92 | $286.21M | |
30.49 | $568.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accelerate Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accelerate Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Accelerate Diagnostics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Accelerate Diagnostics, Inc. (AXDX)?
What is the highest PE Ratio for Accelerate Diagnostics, Inc. (AXDX)?
What is the 3-year average PE Ratio for Accelerate Diagnostics, Inc. (AXDX)?
What is the 5-year average PE Ratio for Accelerate Diagnostics, Inc. (AXDX)?
How does the current PE Ratio for Accelerate Diagnostics, Inc. (AXDX) compare to its historical average?